Human pluripotent stem cell-derived myogenic progenitors undergo maturation to quiescent satellite cells upon engraftment
Copyright © 2022 Elsevier Inc. All rights reserved..
GFP), we demonstrate that hPSC-derived MPCs can contribute to the regeneration of myofibers in mice following local injury and in mice deficient of dystrophin (mdx). We also demonstrate that a subset of PAX7::GFP MPCs engraft within the basal lamina of regenerated myofibers, adopt a quiescent state, and contribute to regeneration upon reinjury and in mdx mouse models. This subset of PAX7::GFP MPCs undergo a maturation process and remodel their molecular characteristics to resemble those of late-stage fetal MPCs/adult satellite cells following in vivo engraftment. These in-vivo-matured PAX7::GFP MPCs retain a cell-autonomous ability to regenerate and can repopulate in the niche of secondary recipient mice, providing a proof of principle for future hPSC-based cell therapy for muscle disorders.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Cell stem cell - 29(2022), 4 vom: 07. Apr., Seite 610-619.e5 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sun, Congshan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 12.04.2022 Date Revised 26.05.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1016/j.stem.2022.03.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM33924853X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM33924853X | ||
003 | DE-627 | ||
005 | 20231226002455.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.stem.2022.03.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n1130.xml |
035 | |a (DE-627)NLM33924853X | ||
035 | |a (NLM)35395188 | ||
035 | |a (PII)S1934-5909(22)00102-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sun, Congshan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Human pluripotent stem cell-derived myogenic progenitors undergo maturation to quiescent satellite cells upon engraftment |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.04.2022 | ||
500 | |a Date Revised 26.05.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
520 | |a Human pluripotent stem cell (hPSC)-derived myogenic progenitor cell (MPC) transplantation is a promising therapeutic approach for a variety of degenerative muscle disorders. Here, using an MPC-specific fluorescent reporter system (PAX7::GFP), we demonstrate that hPSC-derived MPCs can contribute to the regeneration of myofibers in mice following local injury and in mice deficient of dystrophin (mdx). We also demonstrate that a subset of PAX7::GFP MPCs engraft within the basal lamina of regenerated myofibers, adopt a quiescent state, and contribute to regeneration upon reinjury and in mdx mouse models. This subset of PAX7::GFP MPCs undergo a maturation process and remodel their molecular characteristics to resemble those of late-stage fetal MPCs/adult satellite cells following in vivo engraftment. These in-vivo-matured PAX7::GFP MPCs retain a cell-autonomous ability to regenerate and can repopulate in the niche of secondary recipient mice, providing a proof of principle for future hPSC-based cell therapy for muscle disorders | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Duchenne muscular dystrophy | |
650 | 4 | |a mdx mouse | |
650 | 4 | |a pluripotent stem cells | |
650 | 4 | |a quiescent stem cells | |
650 | 4 | |a skeletal muscle stem cells | |
650 | 7 | |a Dystrophin |2 NLM | |
700 | 1 | |a Kannan, Suraj |e verfasserin |4 aut | |
700 | 1 | |a Choi, In Young |e verfasserin |4 aut | |
700 | 1 | |a Lim, HoTae |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Hao |e verfasserin |4 aut | |
700 | 1 | |a Chen, Grace S |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Nancy |e verfasserin |4 aut | |
700 | 1 | |a Park, Seong-Hyun |e verfasserin |4 aut | |
700 | 1 | |a Serra, Carlo |e verfasserin |4 aut | |
700 | 1 | |a Iyer, Shama R |e verfasserin |4 aut | |
700 | 1 | |a Lloyd, Thomas E |e verfasserin |4 aut | |
700 | 1 | |a Kwon, Chulan |e verfasserin |4 aut | |
700 | 1 | |a Lovering, Richard M |e verfasserin |4 aut | |
700 | 1 | |a Lim, Su Bin |e verfasserin |4 aut | |
700 | 1 | |a Andersen, Peter |e verfasserin |4 aut | |
700 | 1 | |a Wagner, Kathryn R |e verfasserin |4 aut | |
700 | 1 | |a Lee, Gabsang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cell stem cell |d 2007 |g 29(2022), 4 vom: 07. Apr., Seite 610-619.e5 |w (DE-627)NLM176526269 |x 1875-9777 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2022 |g number:4 |g day:07 |g month:04 |g pages:610-619.e5 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.stem.2022.03.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2022 |e 4 |b 07 |c 04 |h 610-619.e5 |